genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Boehringer Ingelheim
Artificial Intelligence
Xiaorong He on Boehringer Ingelheim’s Investments in AI, Broader Applications in Pharma
A-Lists
Top 10 Contract Development and Manufacturing Organizations 2024
Drug Discovery
Boehringer Ingelheim, Ochre Bio Launch Up-to-$1B+ Liver Disease Partnership
Drug Discovery
After Mod 2.0, What Can Be Done to Boost Adoption of Alternatives to Animal Models?
A-Lists
Top 10 Contract Development and Manufacturing Organizations
Bioprocessing
Connected Downstream Models for Accurate Process Predictions
Drug Discovery
PhoreMost Achieves Target Discovery Milestone with Boehringer Ingelheim
Drug Discovery
Boehringer Ingelheim, Enleofen Ink $1B-Per-Product Anti-IL-11 Partnership Focused on NASH, Lung Disorders
Cancer
Boehringer Ingelheim, Lupin Launch $700M+ Cancer Therapy Collaboration Targeting KRAS
Industry News
Boehringer Ingelheim Launches Up-to-€1.1B IPF Collaboration with Bridge Biotherapeutics
1
2
3
...
12
Page 1 of 12
Scroll Up
Scroll Up
